tiprankstipranks
Theravance Biopharma downgraded at Evercore ISI after Yupelri trial failure
PremiumThe FlyTheravance Biopharma downgraded at Evercore ISI after Yupelri trial failure
3M ago
Theravance Biopharma downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Theravance Biopharma downgraded to In Line from Outperform at Evercore ISI
3M ago
Theravance Biopharma reports PIFR-2 study missed primary endpoint
PremiumThe Fly
Theravance Biopharma reports PIFR-2 study missed primary endpoint
4M ago
Theravance Biopharma, Teva enter into settlement agreement related to Yupelri
PremiumThe FlyTheravance Biopharma, Teva enter into settlement agreement related to Yupelri
6M ago
Caribou Biosciences appoints Zawadzki as Chief People Officer
PremiumThe Fly
Caribou Biosciences appoints Zawadzki as Chief People Officer
7M ago
Theravance Biopharma reaffirms FY23 R&D expense view $35M-$45M
PremiumThe Fly
Theravance Biopharma reaffirms FY23 R&D expense view $35M-$45M
9M ago
Irenic sends letter to Theravance urging governance overhaul, capital return
PremiumThe FlyIrenic sends letter to Theravance urging governance overhaul, capital return
1y ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100